GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » I rom Group Co Ltd (TSE:2372) » Definitions » Cyclically Adjusted PS Ratio

I rom Group Co (TSE:2372) Cyclically Adjusted PS Ratio : 2.89 (As of Sep. 21, 2024)


View and export this data going back to 2003. Start your Free Trial

What is I rom Group Co Cyclically Adjusted PS Ratio?

As of today (2024-09-21), I rom Group Co's current share price is 円2778.00. I rom Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円962.06. I rom Group Co's Cyclically Adjusted PS Ratio for today is 2.89.

The historical rank and industry rank for I rom Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:2372' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.19   Med: 2.33   Max: 4.31
Current: 2.89

During the past years, I rom Group Co's highest Cyclically Adjusted PS Ratio was 4.31. The lowest was 1.19. And the median was 2.33.

TSE:2372's Cyclically Adjusted PS Ratio is ranked worse than
73.79% of 351 companies
in the Healthcare Providers & Services industry
Industry Median: 1.2 vs TSE:2372: 2.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

I rom Group Co's adjusted revenue per share data for the three months ended in Mar. 2024 was 円402.412. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円962.06 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


I rom Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for I rom Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

I rom Group Co Cyclically Adjusted PS Ratio Chart

I rom Group Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 3.36 2.60 2.26 1.96

I rom Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 2.25 2.11 2.16 1.96

Competitive Comparison of I rom Group Co's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, I rom Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


I rom Group Co's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, I rom Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where I rom Group Co's Cyclically Adjusted PS Ratio falls into.



I rom Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

I rom Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2778.00/962.06
=2.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

I rom Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, I rom Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=402.412/107.2000*107.2000
=402.412

Current CPI (Mar. 2024) = 107.2000.

I rom Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 112.484 98.000 123.044
201409 71.786 98.500 78.126
201412 77.768 97.900 85.156
201503 137.769 97.900 150.856
201506 85.092 98.400 92.702
201509 78.213 98.500 85.121
201512 91.312 98.100 99.782
201603 133.057 97.900 145.697
201606 88.296 98.100 96.487
201609 87.448 98.000 95.657
201612 97.003 98.400 105.678
201703 168.083 98.100 183.675
201706 147.323 98.500 160.335
201709 192.331 98.800 208.683
201712 191.373 99.400 206.390
201803 198.578 99.200 214.592
201806 188.732 99.200 203.952
201809 203.974 99.900 218.879
201812 264.699 99.700 284.611
201903 221.472 99.700 238.132
201906 205.772 99.800 221.030
201909 195.213 100.100 209.059
201912 213.679 100.500 227.924
202003 278.595 100.300 297.761
202006 185.630 99.900 199.195
202009 236.093 99.900 253.345
202012 363.967 99.300 392.923
202103 282.905 99.900 303.578
202106 281.279 99.500 303.046
202109 284.712 100.100 304.906
202112 399.389 100.100 427.717
202203 332.038 101.100 352.072
202206 396.197 101.800 417.213
202209 400.545 103.100 416.474
202212 351.586 104.100 362.056
202303 367.969 104.400 377.838
202306 384.787 105.200 392.102
202309 331.929 106.200 335.055
202312 346.052 106.800 347.348
202403 402.412 107.200 402.412

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


I rom Group Co  (TSE:2372) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


I rom Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of I rom Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


I rom Group Co Business Description

Traded in Other Exchanges
N/A
Address
Iidabashi Grand Bloom 2-10-2 Fujimi, Chiyoda-ku, Tokyo, JPN, 102-0071
I rom Group Co Ltd is a Japan based company engages in provision of medicinal treatment, site management organization, contract research organization, and medical support to pharmaceutical companies.

I rom Group Co Headlines

No Headlines